Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • World
  • Page 118

Category: World

Weekly Biotech News of The World

  • BiotechToday
  • World

Large-Scale Screening based new natural compounds show anti-viral effects on SARS-CoV-2

bioxone October 6, 2020October 5, 2020

Snigdha Ghosh, Amity University Kolkata COVID-19 pandemic has spread tremors around the globe within a few months and this December 2020, it’s going to be one year that we all are combating to formulate and identify such effective drugs against it. Research and multiple clinical trials proved that some anti-viral drugs like – (Remdesivir, Chloroquine) […]

Read More
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Read More
  • BiotechToday
  • World

Studies Showing Connections Between Gut Microbiome And Brain: The Gut-Brain Axis

bioxone October 6, 2020October 5, 2020

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA Studies show that the ageing cycle might be connected with age-related changes in our gut microbiota. Currently, the presence of two-way communication between the gut and the mind – known as the ‘gut-brain axis – has played a significant role in moulding the aspects of behaviour and cognitive function. Researches […]

Read More
  • BiotechToday
  • World

Cardiovascular disease risks in chemotherapy-treated testicular cancer patients

bioxone October 6, 2020October 5, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA Genetic variation is promoting the risk of cardiovascular disease (CVD) in chemotherapy-treated testicular cancer (TC) patients due to alterations of SNPs (Single Nucleotide Polymorphism) from normal sequences. TC patients treated with platinum-based chemotherapy (PBC) when genotyped, were analyzed with 141 independent genomic loci, containing 324 SNPs contributing to CVD occurrence. […]

Read More
  • BiotechToday
  • World

Stem cell response to inflammation may reverse periodontal disease?

bioxone October 6, 2020October 5, 2020

Arjama Roy, Amity University Kolkata. Periodontitis is generally termed as gum disease. It is a chronic inflammatory disease that damages gums and might destroy the jawbone. This can result in extensive tooth loss in severe cases and can impact the systemic well-being of the person.  Earlier, it had been known that the activation of pro-inflammatory […]

Read More
  • BiotechToday
  • World

Climate change and Antibiotic resistance development

bioxone October 5, 2020October 6, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Bacterial infections leading to diseases or in many of the times increasing the severity of another disease are one of the most common issues faced by human beings. Increased resistance against mostly used antibiotics (drugs) is presently the biggest concern for healthcare professionals and the general public. […]

Read More
  • BiotechToday
  • World

Long-term immunity against Coronavirus is a myth

bioxone October 5, 2020October 5, 2020

Devyani Goswami, Amity University Kolkata It is about a year now that the SARS-CoV-2 has disturbed and changed the daily lifestyle of people all over the world. A vaccine against this virus is what we are hoping for, but that too comes with a drawback that it won’t be able to provide a long-term immunity […]

Read More
  • BiotechToday
  • World

CAN GENETIC MUTATION LEAD TO MATERNAL DEATH AFTER CHILD BIRTH?

bioxone October 5, 2020October 5, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA Childbirth is often regarded as a life-changing event, one that is of great concern to the mother and child involved. Sometimes, this phenomenon becomes rather disheartening. It has been observed quite often that due to various unforeseen fatal complexities, these manifest into a disastrous outcome such as when the mother […]

Read More
  • BiotechToday
  • World

The Nobel Prize in Medicine or Physiology 2020- awarded jointly to a triad for discovering the Hepatitis C Virus!

bioxone October 5, 2020October 5, 2020

Richismita Hazra, Amity University Kolkata The “US-UK” triad, Harvey J. Alter, Michael Houghton, and Charles M. Rice, have been awarded jointly, the Nobel Prize for Medicine or Physiology for the discovery of the Hepatitis C virus. Scientists will share the prestigious Nobel prize sum of 10 million Swedish kronor (about $1.1 million, 950,000 euros). Hepatitis […]

Read More
  • BiotechToday
  • India
  • World

Organic Pesticides- a boon or a bane?

bioxone October 5, 2020October 5, 2020 1

Shrayana Ghosh, Amity University Kolkata To ensure a stable food supply, it is necessary to protect crops against pests and diseases. Roughly 95% of food comes from organic cultivation, using chemical pesticides to preserve the quality of the crops. But organic pesticides are increasingly being pursued as an option as well. Some organic pesticides contain […]

Read More

Posts navigation

1 … 114 115 116 117 118 119 120 121 122 … 131

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy